Cite
HARVARD Citation
Zhu, F. et al. (2015). Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet. 385 (9984), pp. 2272-2279. [Online].